EYE ON CHINA

2013 ◽  
Vol 17 (09) ◽  
pp. 18-25

Agilent Technologies recognized by Frost & Sullivan as 2013 Laboratory Analytical Instrumentation Company of the Year in China. Verisante Technology, Inc. announces study on nasopharnygeal cancer in China. ICON signs collaboration agreement with the Taiwan National Centre of Excellence for clinical trials and research. MicuRx completes $25 million Series B financing. Connecticut's CURE network welcomes HLK, its first Chinese member company. 2013 BIO Convention in China to connect biotech industry to the world's 2nd largest biopharmaceutical market. Partner State Key Laboratory of Pharmaceutical Biotechnology opened at HKU. Amgen and ShanghaiTech University announce plans for Amgen China R&D center to open on ShanghaiTech campus. CANbridge Life Sciences enters into agreement with Azaya Therapeutics to develop ATI-1123 for lung cancer in China and North Asia.

Author(s):  
Marion E. Glick

Public relations is not just sending out a press release or invitations to an event. It is the profession of managing communications between an organization and its audiences. As a public relations professional, you develop and execute communications programs that consider and support such corporate goals as reputation, the selling of products or services, recruitment of employees, or encouragement of investments. You can do this as an in-house professional at the company or as a client service if you work in an agency. If you want to apply your science journalism skills to corporate public relations, they will be highly prized by pharmaceutical, biotechnology, medical device, technology, and related companies. You not only comprehend the facts about environmental, physical, or life sciences, you can make them understandable to others. You can accurately and efficiently translate the function and value of a product or service to audiences as varied as customers, stockholders, regulators, and journalists, all of whom have different levels of scientific understanding. But being savvy about the scientific process and journalism is not enough. You also have to understand the business. Yes, it is about the money or, rather, commercial decision-making. To do your job well, you must know how the company makes money, who runs the show, who are the customers, how the business will grow, how it is regulated, and who are the existing or potential partners and competitors. And you should know these aspects as well as you know the company's research and development pipeline, patents, or marketed products or services. As someone who made the transition from managing public relations about medical research for academic and governmental organizations to that of Pharmaceuticals and biotechs, I can say that mastering “the business stuff” is possible. Many excellent resources are available, but start by skimming business magazines, checking out Hoover's Online (www.hoovers.com), and reading the annual reports of your company or clients. To manage corporate public relations, you need a program, which is the blueprint that captures the vision and the means to obtain it. Programs are very structured and have goals, objectives, strategies, and measurable tactics to achieve them.


2018 ◽  
Vol 86 (4) ◽  
pp. 328
Author(s):  
Joanna Bartkowiak-Wieczorek ◽  
Ewa Kamińska ◽  
Michał Szulc ◽  
Joanna Domagała ◽  
Przemysław Ł. Mikołajczak ◽  
...  

University of Medical Sciences participates in the realization of the project titled: „Development of the technology of producing cannabinoids from low THC hemp for use as preparations supporting treatment in oncological patients” awarded by the National Centre for Research and Development under project number: INNOMED/I/11/NCBR/2014. The duration of the grant is 36 months, and the total value of the grant is 28011845 PLN. The project is run by University of Life Sciences in Poznan. Laboratory of Experimental Pharmacogenetics at the Department of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences (PUMS) is realizing the task number 4 titled “Evaluation of efficacy and mechanisms of action of Cannabis sativa extracts with analgesic, anti-inflammatory and antiemetic properties in an in vivo model.” The aim of this project is the development of cannabinoid extract with reduced psychoactive component (THC), which due to its high content of cannabidiol (CBD) is meant to provide analgesic properties, and at the same time to reduce the risk of addiction and overdose. University of Medical Sciences is evaluating the analgesic, anti-inflammatory and antiemetic properties of the extract of Cannabis sativa in animal models coupled with neuropathic pain. Pharmacodynamic effects of plant extracts will be later assessed taking into account the level of selected genes and proteins expression.


1969 ◽  
Vol 15 (2) ◽  
Author(s):  
Jane G Tirrell ◽  
Thomas Gregory Dewey

Keck Graduate Institute of Applied Life Sciences (KGI) offers a 2-year professional masters degree programme designed to educate scientists and engineers for leadership positions in the pharmaceutical, biotechnology and medical device industries. Inquiry through team-based projects is a central feature throughout the Master of Bioscience (MBS) curriculum. This paper presents KGI's team-based pedagogy through examples of specific team projects in the MBS curriculum. The projects described begin with the initial projects given to entering students during orientation week and culminate with the Team Masters Projects, the capstone experience of the MBS curriculum. The rationale for KGI's use of team-based learning and the effectiveness of a team-based approach are discussed. The pedagogy described may serve as a useful model for other professional or applied science programmes.


2013 ◽  
Vol 17 (10n11) ◽  
pp. 17-22

Suzhou Amerigen Pharmaceuticals Co., enters into a marketing and distribution agreement with Sinochem Jiangsu Pharmaceutical Co., Ltd. Japanese Encephalitis vaccine achieves WHO prequalification. Hutchison MediPharma enters cancer therapy collaboration with Lilly. Miraculins to negotiate licensing rights for diabetes test in China. Pall opens new Life Sciences Centre of Excellence in Shanghai. Guo Guangchang enters the field of medical tumour treatment. WuXi AppTec receives CLIA certification for its genomics clinical laboratory. Agilent Technologies Thought Leader award supports Dr Guibin Jiang, Chinese Research Center for Eco-Environmental Sciences.


2015 ◽  
Vol 51 (1) ◽  
pp. 1-13 ◽  
Author(s):  
S. M. Cotton ◽  
K. M. Filia ◽  
A. Ratheesh ◽  
K. Pennell ◽  
S. Goldstone ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document